sec v. spencer pharmaceutical inc et al doc 125 filed 14 oct 14.pdf

Upload: scionscion

Post on 02-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    1/6

    r

    UNITED STATES DISTRICT COURT

    FORTHE

    DISTRICT

    OF

    MASSACHUSETS

    t ' '

    lfII40CT

    r

    P f: O

    SECURITIES

    AND

    EXCHANGE

    COMMISSION,

    ,

    Plaintiff,

    .

    SPENCER PHARMACEUTICAL INC.

    MAXIMILLIEN ARELLA

    Civil Action No. 12cv-12334-IT

    IAN MORRICE

    JEAN-FRANCOIS AMYOT

    HILBROY ADVISORY INC.

    lAB MEDIA INC.

    Defendant.

    RESPONSE

    TO PLAINTIFF'S OPPOSITION TO DEFENDANT

    JEAN-FRANCOIS

    AMYOT'S MOTION

    TO COMPEL JOINDER OF DEFENDANTS

    Defendant, Jean-Francois

    Amyot

    hereby files this response to the Plaintiff's opposition

    to

    the

    Motion to Compel Joinder Defendants, Rami Ailabouni, Rod Zimmer, The Canadian

    Government, Francis

    Mailhot

    RainMaker Venture Capital, RainMaker Global, Christian

    Saunders, Tlllerrnan Securities, Cunningham-Adams Small Cap Fund, Cunningham-Adams Green

    Fund, Strategema Capital, Sterling Stock Investment Ltd, Karol Schlosser, Alain Houle, Stephane

    Goulet, Gous Inc., Anny Yamashita, Joseph Emas, the University of Quebec in Montreal, Dr.

    Alexandruu Mateescu, Dian Dalmy, Mitch Segal, Alexey Nikitin, Lesco, Dr. Bandar AI-Dhafiri, and

    L'Autorite des Marches Financiers du Quebec.

    The Defendant understand

    that

    this

    motion

    was

    time

    sensitive since

    it

    is made less than

    two month before the scheduled trial, but defendant has only learned of the possibility of said

    motion days prior

    to

    filing it. I apologize

    to

    the court for not being fully versed as the Plainti ff in

    manner

    of

    law and its procedures and we appreciate

    the court

    consideration of

    our

    limited

    ability in fil ing such a

    motion.

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 1 of 6

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    2/6

    The Plaintiff's claims are based on the allegations that Spencer Pharmaceutical released false

    and misleading press releases on its business, its technology as well as press releases on a

    buyout

    offer

    from a company said

    to

    be located in the Middle East The alleged

    False

    and

    Misleading press release are said to have had the effect

    of

    increasing

    the

    demand for the shares

    of

    Spencer Pharmaceutical, which has resulted in the increase in the price

    of

    the shares,

    enabling some shareholders to sell their shares for a profit hence the so called pump and

    dump .

    In the Plaintiff's distorted view, I am a puppet master who orchestrated, controlled, and

    directed several individuals, companies, and institutions to perpetrate the allege pump and

    dump scheme. If

    the

    Plaintiff

    truly

    believed

    that

    I was the

    puppet

    master , it would not have

    included Defendant Dr. Arella, Mr. Morr ice, Spencer Pharmaceutical, Hilbroy Advisory or lAB

    Media, and the reason they included these individual is because according to the Plaintiff's

    believe, these individuals and or entities have a part or all

    of

    the responsibilities as per their

    claim. For this reason, individuals and or entit ies requested to be joined as defendant, are not

    simply witnesses, but in the Plaintiff's own belief, they are also partly

    or

    completely responsible

    for the alleged wrong doings.

    In such, all discovery thus far, have proven to the Plaintiff's that certain individual such as Rami

    Ailabouni are responsible

    for

    some

    of

    the claims made by

    the

    Plaintiff against the defendants.

    In addition, through

    their

    own opinion expressed in the claims made on December 17, 2012,

    The Plaintiff list many

    of

    the individuals and entities as being responsible for the allege wrong

    doing and therefore, it is indispensable that they be joined as defendant.

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 2 of 6

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    3/6

    As per the Plaintiff's opposition to the motion of joinder defendant (page 3), - Congress

    awareness

    th t the

    purpose of

    SE

    actions differs from

    th t

    of private action. That is, the

    SE

    seeks to protect the investing public, while private actions for damages seek

    to

    adjudicate a

    private controversy against citizens .

    It is therefore imperative

    th t

    Joinder Defendant be ordered in order for

    the

    SE action to fulfill

    its mandate to protect the investing public against the joinder defendants' actions and

    responsibilities towards the cited claims.

    The Plaintiff makes an erroneous interpretation

    of

    Section 21(g)

    of

    the Securities Act since the

    clause is meant to deny any

    third

    party claim, or joinder Plaintiff be ordered in order not to

    lessen

    or

    limit

    relief sought by

    the

    Plaintiff,

    but

    not

    to

    prevent

    joinder

    defendant, especially not

    when the Plainti ff is provided evidence to dispute their own beliefs.

    It is therefore indispensable

    th t

    Joinder Defendant be ordered because

    the

    Defendants will be

    subject to substantial risk of

    incurring double, multiple or otherwise inconsistent obligations

    because

    of

    the interest.

    The Plaintiff claims th t

    the joinder

    defendant is not indispensable because

    the

    district court

    has wide latitude to order disgorgement amount and th t the Defendant can be heard at a post

    tria l proceedings. However, again

    the

    Plaint iff fails to address

    the

    double, multiple or

    otherwise inconsistent obligations arising from the numerous allegation of violations of the

    Securities Act, namely violation of Section 17(a)(1) and (3) (b) and Section lO(b), Rule lOb

    5(a)(c) etc. as well as permanent injunctions which will subject the Defendant to substantial risk

    of incurring double, multiple or otherwise inconsistent obligations and therefore not only

    monetary obligations if the jury believes the Plaintiff's claims against the Defendant.

    As per the Autorite des Marches Financiers du Quebec, this court has ruled on forum non

    convenient without prejudice unt il discovery is completed. We continue to believe th t this

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 3 of 6

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    4/6

    forum is

    not

    adequate and this

    m tter

    should be decided in Canadian courts. However, since

    the AMF claims th t it was aware and was following every action by Spencer and or the

    defendants and did not act, they should be joined as defendant. The AMF claims to have the

    jurisdiction over this action as well as other United States issuers. The AMF did not make any

    attempts to request from Spencer, Hilbroy, lAB Media, UQAM, or the Canadian Government

    any information whatsoever to confirm, or otherwise deny the press releases by the company.

    The AMF watched, took note of every action Spencer did without any ttempt to protect the

    investing public and therefore are not just witnesses, but are responsible for their inaction. The

    current case AMF v Amyot provides the basis for the AMF claiming jurisdiction over

    US

    Publicly

    Traded companies and

    US

    Capital Markets and therefore the AMF provides for an exception to

    the

    FSIA

    and should

    not

    be covered by the Foreign Sovereign Immunity Act

    if

    in fact the AMF is

    considered a Foreign State as defined in the Act. It is therefore indispensable th t the AMF be

    ordered by the court asJoinder Defendant.

    As it concerns the defendant s failure to call any witness during the discovery period; this is only

    due to the lack of financial resources to pay

    for

    the court reporter and conference room rental.

    The defendant had planned to call 20 witnesses, but the Plaintiff s refused the Defendant s

    request to have them pay for the court reporter and therefore the cost of said court reporter

    created our inability to call witnesses. As far as providing notice

    for

    witnesses subpoena by the

    Plaintiff, the Defendant only learned after the fact;

    th t

    it also had to provide notice in order to

    have equal time during deposition. We therefore did not get much time questioning any

    witnesses during

    their

    deposition.

    The joinder defendants are indispensable to this case since the claims made by the Plaintiffs as

    per the December 17, 2012 claims related to several individuals and entities th t are not mere

    witnesses, but were directly responsible for the allege claims. In addition, the Plaint iff received

    confirmation during deposition th t their claims made against the defendants were in fact

    erroneous and said claims should be made against the listed Joinder Defendants.

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 4 of 6

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    5/6

    Notwithstanding that the Plaintiff imperative requirement

    to

    protect the investing public and

    pursue individuals and or entities believed to be responsible, rejecting Joinder Defendants

    would fundamentally deter from

    its enforcement objective, therefore potentially challenging

    Section 21 g) and if so, we would make a motion for Joinder Plaintiff since the actions of Mr.

    Ailabouni, Rod Zimmer,

    the

    Canadian Government, the University,

    the

    AMF have cause

    irreparable prejudice onto

    the

    defendants.

    We thank you

    for accepting our response

    to

    the Plaintiffs opposition on motion for joinder and

    we request the court to order the otion for Joinder Defendant.

    Respectfully,

    October 8,2014

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 5 of 6

  • 8/10/2019 SEC v. Spencer Pharmaceutical Inc et al Doc 125 filed 14 Oct 14.pdf

    6/6

    CERTIFIC TE O SERVICE

    I Jean-Francois Amyot hereby certify th t a

    true

    copy of

    the

    above document was sent

    on October 8 2014 by electronic mail and overnight mail

    Case 1:12-cv-12334-IT Document 125 Filed 10/14/14 Page 6 of 6